Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002123843-26-000002
Filing Date
2026-03-27
Accepted
2026-03-27 19:47:04
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 form3-03272026_110300.html 3  
1 form3-03272026_110300.xml 3 10661
2 ex24-03272026_110304.htm EX-24 5638
  Complete submission text file 0002123843-26-000002.txt   17723
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Javadi Alireza (Reporting) CIK: 0002123843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40672 | Film No.: 26809552